Fundraising Fox

Scout Bio Inc

Acquired

Philadelphia, US · Founded 2016 · Delaware corporation · 4 known investors

scoutbio.co

Scout Bio developed biotechnology therapies for pets, including a pipeline of monoclonal antibodies and gene therapy programs targeting chronic diseases in companion animals. The company was acquired by animal health firm Ceva in early 2024, and its work now operates as Ceva's biotechnology campus in Philadelphia.

AgTechBiotechDeep TechHealthtech

Founders & leadership

MHMark Hefferman
Mark HeffermanExecutive

Board

AKAditya Kohli
Aditya KohliinBoard directorPartner at Frazier Life Sciences
TY
Tadataka YamadaBoard director
PHPatrick Heron
Patrick HeroninBoard directorManaging Partner at Frazier Life Sciences
CCCindy Cole
Cindy ColeinBoard directorTechnical Partner at Digitalis Ventures
NH
Nancy HongBoard director

Investors · 4

Reported raises · per SEC filings

Form D private placements

$34M disclosed across 3 rounds · 2018–2021

$4.8MraisedOct 2021 · 6 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Damian LismoreExecutive Officer
  • Nancy HongDirector
  • Cindy ColeDirector
  • Mark HeffermanExecutive Officer, Director
  • Aditya KohliDirector
  • Patrick HeronDirector
Offering amount
$13M
Amount sold
$4.8M
First sale
Oct 2021
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$20MraisedApr 2019 · 6 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Aditya KohliDirector
  • Mark HeffermanExecutive Officer, Director
  • Tadataka YamadaDirector
  • Patrick HeronDirector
  • Cindy ColeDirector
  • Nancy HongDirector
Offering amount
$20M
Amount sold
$20M
First sale
Mar 2019
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$9.3MraisedMar 2018 · 4 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Remy DurandDirector
  • Krishna PoluExecutive Officer, Director
  • Tadataka YamadaDirector
  • Kevin MahoneyDirector
  • Patrick HeronDirector
Offering amount
$9.3M
Amount sold
$9.3M
First sale
Feb 2018
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 2

by search overlap

Companies competing with Scout Bio Inc for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Scout Bio Inc do?
Scout Bio developed biotechnology therapies for pets, including a pipeline of monoclonal antibodies and gene therapy programs targeting chronic diseases in companion animals. The company was acquired by animal health firm Ceva in early 2024, and its work now operates as Ceva's biotechnology campus in Philadelphia.
Who are Scout Bio Inc's investors?
Scout Bio Inc's investors include Companion Fund, Digitalis Ventures, Frazier Life Sciences, RiverVest Venture Partners.
How much funding has Scout Bio Inc raised?
Scout Bio Inc has disclosed $34M raised across 3 rounds.
Where is Scout Bio Inc headquartered?
Scout Bio Inc is headquartered in Philadelphia, US.